🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalNew Zealand Medsafe — GLP-1 scheduling and Pharmac funding Page 3

New Zealand Medsafe — GLP-1 scheduling and Pharmac funding

pat_auckland Thu, Mar 5, 2026 at 12:45 AM 18 replies 668 viewsPage 3 of 4
gary_naperville
Member
245
1,123
Oct 2024
Naperville, IL
Mar 5, 2026 at 5:00 AM#11

Thank you newstart_MO! This is incredibly helpful. Bookmarking for later. 🙏

39 4SleepFixSam, PurityPaulOR, MaxMetOK and 36 others
Reply Quote Save Share Report
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Mar 5, 2026 at 5:17 AM#12

Slightly tangential to New Zealand Medsafe but pat_auckland reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

19 4BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 16 others
Reply Quote Save Share Report
TomTeleRx
Member
189
678
Feb 2025
Delaware
Mar 5, 2026 at 5:34 AM#13

Thanks for sharing this, pat_auckland. A few questions about your New Zealand Medsafe experience:

  1. What dose did you start at?
  2. How long before you noticed side effects improving?
  3. Did your provider have any specific recommendations about New Zealand?

I am in a similar boat and trying to learn from others' experiences before my next appointment.

Last edited: Mar 5, 2026 at 6:34 AM
43 15LibrarianMeg, bri_stats, pete_manc_UK and 40 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Mar 5, 2026 at 5:51 AM#14

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on New Zealand Medsafe .

To answer jim_asheville: my doctor and I discussed the options and went with brand.

Quick update: I have noticed more improvement since posting this. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

Last edited: Mar 5, 2026 at 9:51 AM
1 23MeganSA_TX
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Mar 5, 2026 at 6:08 AM#15

Adding my data to this New Zealand Medsafe discussion:

MetricBaselineMonth 3Month 6
Weight252 lbs232 lbs207 lbs
A1C6.6%5.8%5.2%
hsCRP6.02.01.0

Protocol: Semaglutide 2.4mg/wk, resistance training 3x/wk, protein 1.4g/kg/day.

34 21Dr.GutHealth, amsterdam_pete, LondonLisa and 31 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register